NT 10-K/A

FORM 12B-25AMENDED

Company: Ernexa Therapeutics Inc.
Filed: March 16, 2004
Period of Report: December 31, 2003
Accession Number: 0000748592-04-000023

View Document ↗ View on SEC.gov ↗